FY01 Supply Solutions Operating Margin Expansion Drivers
Created focused management team with aligned goals and incentives
Increased buying leverage
Increased penetration for proprietary generic drug offerings
Improved back-office processes
Expanded Six Sigma benefits
Leveraged pharmaceutical DC network